Vascular endothelial growth factor (VEGF)-targeted therapy for the treatment of adult metastatic Xp11.2 translocation renal cell carcinoma

INTRODUCTION: Adult “translocation” renal cell carcinoma (RCC), bearing TFE3 gene fusions at Xp11.2, is a recently recognized unique entity for which prognosis and therapy remain poorly understood. We investigated the effect of vascular-endothelial growth factor (VEGF)-targeted therapy in this disti...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Cancer
Auteurs principaux: Choueiri, Toni K., Lim, Zita Dubauskas, Hirsch, Michelle S., Tamboli, Pheroze, Jonasch, Eric, McDermott, David F., Cin, Paola Dal, Corn, Paul, Vaishampayan, Ulka, Heng, Daniel Y.C., Tannir, Nizar M.
Format: Artigo
Langue:Inglês
Publié: 2010
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4667556/
https://ncbi.nlm.nih.gov/pubmed/20665500
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.25512
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires